Copyright: ©Author(s) 2026.
World J Hepatol. Jun 27, 2026; 18(6): 120789
Published online Jun 27, 2026. doi: 10.4254/wjh.120789
Published online Jun 27, 2026. doi: 10.4254/wjh.120789
Table 1 Therapeutic potential of kaempferol across various experimental models
| Ref. | Model | Route | Findings |
| Baghaei et al[42], 2022 | HepG2 cells | Enhanced fatty acid oxidation and reduced lipogenesis | |
| BinMowyna and AlFaris[44], 2021 | Mice | Orally | Anti-diabetic effect via activating the AMPK pathway |
| Park et al[43], 2025 | Rats | Orally (250 mg/kg BW) | Decreased the acetylation of all SIRT1 targets, including PARP1, NF-κB, FOXO-1 and p53 that mediate antioxidant, anti-inflammatory and anti-apoptotic effects |
| Aodah et al[45], 2024 | HepG2 C8 cells | Upregulation of antioxidant response elements (ARE)-mediated antioxidative enzymes, such as heme oxygenase, catalase and superoxide dismutases under the control of Nrf2 signaling pathways | |
| Saw et al[46], 2014 | Mice | Orally (25, 50, 100 mg/kg BW) | Reduced CCl4-induced liver damage via restoring gut microbiota diversity, increasing beneficial genera (e.g., Lactobacillus), and activating Nrf2 signaling |
| Alkandahri et al[52], 2023 | Mice | Intraperitoneal (2.5, 5, 10, 20, 40 mg/kg BW) | Increased the expression of Grp78, decreased the expression of CHOP, and protected hepatocytes from ER stress-induced apoptosis |
| Shi et al[58], 2025 | Rats | 50 mg/kg BW | kaempferol-loaded nanoparticles (KFP-NPs) improved the antioxidant defense, evidenced by increased levels of SOD, GPx, and Nrf2 in SD rats |
| Qu et al[60], 2025 | Raw 264.7 macrophage | 24 μmol/L drugs | Kaempferol-loaded fibroin nanoparticles downregulate the expression of TNF-α and eliminate the intracellular reactive oxygen in raw macrophages |
- Citation: Sharma V, Patial V. Protective effects of kaempferol against diet-induced metabolic disorders. World J Hepatol 2026; 18(6): 120789
- URL: https://www.wjgnet.com/1948-5182/full/v18/i6/120789.htm
- DOI: https://dx.doi.org/10.4254/wjh.120789